Sample Internet Enduring Landing Page

This is a sample landing page for an internet enduring CME activity that is charging registration and has commercial support. Please use this as a guide when designing your webpage, and update the appropriate sections as it relates to your activity.

Update in Internal Medicine

Presented by
John Smith, MD
Professor of Medicine
College of Medicine
University of Florida

Price
$0 for UF Participants
$45.00 non-UF Participants

Program Description

This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is one hour.

Learning Objectives

As a result of participation in this activity, participants should be able to:

  1. [Learning Objective 1]
  2. [Learning Objective 2]
  3. [Learning Objective 3]

Faculty Disclosure

SPEAKER NAME, PLANNING COMMITTEE has disclosed that HE/SHE has no relevant financial relationships. No one else in a position to control content has any financial relationship(s) to disclose.

 

— OR–

 

SPEAKER NAME, PLANNING COMMITTEE has disclosed that HE/SHE received research grant funds from COMPANY and is on Speakers Bureaus for COMPANIES. No one else in a position to control content has any financial relationships to disclose.

Continuing Medical Education Credit

Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date

[DATE]

Expiration Date

[DATE]

Target Audience

Primary Care Physicians, …

Resources for Further Study

  1. [Resource]

Commercial Support
This activity is supported by an educational grant from ABC Pharmaceuticals.